SPRB — Spruce Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- $28.81m
- -$64.19m
- $10.09m
- 21
- 45
- 24
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13.1 | -29.5 | -42.3 | -46.2 | -47.9 |
Depreciation | |||||
Non-Cash Items | 0.196 | 0.821 | 4.39 | 3.29 | 4.22 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.263 | 1.16 | 1.96 | 1.13 | 10.4 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -12.6 | -27.5 | -35.9 | -41.7 | -33.3 |
Capital Expenditures | -0.004 | -0.074 | -0.093 | -0.008 | -0.007 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -79.1 | 23.7 | 55.8 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.004 | -0.074 | -79.2 | 23.7 | 55.8 |
Financing Cash Flow Items | — | -2.9 | -0.039 | -0.319 | -3.03 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 12.4 | 181 | 0.643 | -0.241 | 49.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.188 | 153 | -114 | -18.2 | 71.6 |